HealthcareServices

Global Ribonucleic Acid (RNA) Sequencing Industry Trends: Where the Market Is Headed by 2029

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Ribonucleic Acid (RNA) Sequencing Market Expected To Become By 2029 Compared With Its 2025 Level?

The ribonucleic acid (rna) sequencing market has experienced substantial expansion in recent years. It is forecast to grow from $3.25 billion in 2024 to $3.96 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 21.8%. The historical growth for this market can be attributed to an increasing number of drug development activities, a higher prevalence of genetic disorders and target diseases, the growing adoption of miniaturized portable instruments, wider use of biomarker profiling, rising demand for personalized medicine, and the increasing population of cancer patients.

The ribonucleic acid (rna) sequencing market is anticipated to experience significant expansion in the coming years. This market is projected to reach $8.34 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 20.5%. This expansion during the forecast period is driven by several factors, including an increased need for quick and precise disease diagnosis, the rising integration of real-time polymerase chain reaction, a greater call for swift and localized diagnostic testing, an uptick in infectious disease outbreaks, and the necessity for companion diagnostics. Key trends anticipated within this period encompass disease detection and monitoring, advancements in drug discovery, target validation, identification of biomarkers, innovations in DNA sequencing technologies, improvements in diagnostic testing, the evolution of next-generation sequencing (NGS), the application of microfluidics, the use of lab-on-a-chip platforms, and the development of sophisticated molecular diagnostic solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15665&type=smp

Which Drivers Are Shaping The Ribonucleic Acid (RNA) Sequencing Industry’s Market Share?

The ribonucleic acid (RNA) sequencing market is anticipated to expand, driven by a growing emphasis on precision medicine. This innovative medical strategy, also known as personalized medicine, focuses on treatment and prevention by accounting for individual differences in genetics, environment, and lifestyle. Its potential lies in offering more effective treatments, spurred by genomic progress, the growing complexity of diseases, and favorable regulatory backing. RNA sequencing technologies are employed to identify the sequence and measure the expression levels of RNA molecules in a given sample, enabling a thorough analysis of transcriptomes, revealing gene expression patterns, alternative splicing events, and RNA modifications. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit organization, indicated that the FDA sanctioned 16 new personalized therapies for rare disease patients in 2023, an increase from six in 2022. Consequently, the heightened attention on precision medicine is a key driver for the ribonucleic acid (RNA) sequencing market.

What Are The Emerging Segments Gaining Attention In The Ribonucleic Acid (RNA) Sequencing Market?

The ribonucleic acid (rna) sequencingmarket covered in this report is segmented –

1) By Product Type: Instruments; Reagents And Kits; Software

2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing

3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications

4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments

2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits

3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software

How Are Emerging Market Trends Shaping The Ribonucleic Acid (RNA) Sequencing Industry Landscape?

Leading companies operating in the ribonucleic acid (RNA) sequencing market are prioritizing RNA next-generation sequencing assay to enhance patient care through data-driven insights and precision medicine. The RNA next-generation sequencing assay functions as a next-generation exome sequencing platform, leveraging advanced genomic sequencing technologies to analyze a patient’s entire exome. For example, in June 2023, Tempus, a US-based precision medicine technology company, launched its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, developed for solid tumors, delivers a comprehensive analysis of the entire transcriptome, underscoring clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This specific offering serves physicians with a particular interest in RNA fusions or altered splicing, alongside providers, researchers, and biopharma companies desiring detailed RNA sequencing analysis of their existing samples.

Who Are The Major Companies Operating In The Ribonucleic Acid (RNA) Sequencing Market?

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Genomics Inc., Natera Inc., Myriad Genetics Inc., BGI Genomics Co Ltd., Takara Bio Inc., Cepheid, NeoGenomics Laboratories Inc., Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., Macrogen Inc., Standard BioTools Inc., Ambry Genetics Corporation, Biocartis SA, CD Genomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Which Regional Markets Are Contributing Most To The Ribonucleic Acid (RNA) Sequencing Industry Expansion?

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Ribonucleic Acid (RNA) Sequencing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15665&type=smp

Browse Through More Reports Similar to the Global Ribonucleic Acid (RNA) Sequencing Market 2025, By The Business Research Company

Induction Furnace Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/induction-furnace-global-market-report

Alternative Fuel Vehicles Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/alternative-fuel-vehicles-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795